If you are an Ochsner provider and need assistance with this site please email
[email protected]
.
ScholarlyWork@Ochsner
Toggle navigation
Browse
Home
People
Organizations
Research Areas
Publications
Capability Map
Nature Medicine
Journal
Overview
Identity
View All
Overview
Publication venue for
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)
2022
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
. 26:878.
2020
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
. 26:878.
2020
Identity
International Standard Serial Number (ISSN)
1078-8956
